Skip to main content

Small Link Seen for Acute Kidney Injury, Worsening of Kidney Function in CKD

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, July 13, 2023 -- For patients with chronic kidney disease (CKD), the association between mild-to-moderate acute kidney injury (AKI) and worsening subsequent kidney function is small in fully adjusted models, according to a study published online July 11 in the Annals of Internal Medicine.

Anthony N. Muiru, M.D., M.P.H., from the University of California in San Francisco, and colleagues conducted a multicenter prospective cohort study involving 3,150 patients with CKD to examine the independent association with subsequent kidney function trajectory.

The researchers found that 433 participants had at least one AKI episode during a median follow-up of 3.9 years. Of the episodes, 92 percent had stage 1 or 2 severity. After AKI, there were decreases seen in estimated glomerular filtration rate (eGFR) based on serum creatinine levels and based on cystatin C levels (−2.30 [95 percent confidence interval, −3.70 to −0.86] and −3.61 [−6.39 to −0.82] mL/min/1.73 m2, respectively). The decreases were attenuated to −0.38 (−1.35 to 0.59) and 0.15 (−2.16 to 1.86), respectively, in fully adjusted models. Estimates of changes in eGFR slope after AKI determined by serum creatinine or cystatin C levels were also not significant (0.04 [−0.30 to 0.38] and −0.56 [−1.28 to 0.17] mL/min/1.73 m2, respectively, per year).

"This study more rigorously addressed methodological limitations presented in prior published studies to conclude that the independent association between mild-to-moderate AKI and worsening subsequent kidney function trajectory appears to be small," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

Women Face Worse Chronic Kidney Disease Management in Primary Care

MONDAY, May 20, 2024 -- Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter published online May 16 in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.